Dr. Anne Timm, CEO
Anne worked for more than 30 years in the chemical industry holding various positions like Business Line Head (P&L), Global Key Account Manager and Head of Sales for various markets like pharma, medical devices, consumer care and crop protection. Anne started in 2018 as CBO at INOFEA and moved into the role as CEO in March 2019.
Prof. Dr. Patrick Shahgaldian, CSO
Patrick is Professor at the University of Applied Sciences (FHNW) near Basel, where he leads the Molecular Nanotechnology research group. He is the main inventor of the enzzen®- technology platform and co-founder of INOFEA. Patrick is the author of more than 90 peer-reviewed publications and of a dozen of patents. He is not on INOFEA’s payroll but supports INOFEA with his scientific experience
Dr. Rita Correro, CTO
Rita started at INOFEA in 2017, first as Head of R&D and she is now responsible as CTO for R&D, Production and QA and as Group Leader for biocatalysis in small molecule API manufacturing. She developed INOFEA’s technology at FHNW as postdoc and graduated with a PhD in Biology focusing on Biochemistry at ETH Zurich.
Dr. Agnese Pisano, R&D Group Leader IVT
Agnese earned her Master of Science (M.Sc.) in Molecular and Industrial Biotechnologies from the University of Naples "Federico II" and her Ph.D. in RNA Biology from the University of Zurich. She has joined INOFEA as R&D Group Leader for IVT (In Vitro Transcription). Agnese is an expert in RNA processing enzymes and is passionate about the field of In Vitro Transcription. Her expertise significantly contributes to the company's strategic focus on Biologics. Agnese has developed valuable leadership skills, making her a strong asset in driving INOFEA's ambitious goals.
Dr. Aaron Debon, R&D Group Leader Enzymatic Bioconjugation
Aaron completed his master’s degree in interdisciplinary sciences, followed by a PhD thesis on protein engineering at ETH Zürich. During his tenure at Novartis as a postdoc, he focused on enzymatic peptide modification and bioconjugation. At INOFEA, he contributes his expertise as an R&D group leader in bioconjugation to further advance INOFEA‘s vision of enzymatically produced bioconjugates.
Emilio Cutrona, Scientific Lab Associate
Emilio got a Master degree in Biotechnology for the Industry and for the Scientific Research at the University of Palermo (Italy) and he worked on our technology at FHNW in Muttenz for more than one year before joining INOFEA.
Alexie Bobe, Scientific Lab Associate
With a Chembiotech (Chemistry and Biotechnology) Engineering Degree at the University of Strasbourg and three Research Internships – Technological University of Dublin, CNRS and Matís – Alexie has a strong scientific background and she’s very familiar with enzymology techniques.